Lupin bags USFDA tentative approval for Dasatinib Tablets; stock jumps ~2%
Dasatinib Tablets (RLD Sprycel) has expected annual sales in the United States of USD 1,569 million, as per the IQVIA MAT June 2022.
Source: indiainfoline.com
Stay updated with breaking news from Sprycel Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dasatinib Tablets (RLD Sprycel) has expected annual sales in the United States of USD 1,569 million, as per the IQVIA MAT June 2022.
Dasatinib Tablets have an estimated market size of US$ 1465 million for twelve months ending Dec 2021 according to IQVIA.